CYTK - Cytokinetics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CYTK is currently covered by 16 analysts with an average price target of $99.66. This is a potential upside of $34.04 (51.87%) from yesterday's end of day stock price of $65.62.

Cytokinetics's activity chart (see below) currently has 404 price targets and 383 ratings on display. The stock rating distribution of CYTK is 91.3% BUY and 8.7% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.02% with an average time for these price targets to be met of 366.55 days.

Highest price target for CYTK is $140, Lowest price target is $56, average price target is $99.66.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 31-Aug-2026. First documented stock forecast 26-Jun-2013.

Best performing analysts who are covering CYTK - Cytokinetics:

James Condulis David Lebowitz Akash Tewari Leonid Timashev Mayank Mamtani

Currently out of the existing stock ratings of CYTK, 42 are a BUY (91.3%), 4 are a HOLD (8.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Mar-2014

$140

$75.34 (116.52%)

$140

1 months ago
(31-Aug-2026)

43/72 (59.72%)

$69.09 (97.43%)

793

Buy Since 09-Dec-2022

$103

$38.34 (59.29%)

$97

1 months 18 days ago
(13-Aug-2026)

12/14 (85.71%)

$29.55 (40.23%)

272

Buy Since 20-Dec-2022

$112

$47.34 (73.21%)

$92

1 months 21 days ago
(10-Aug-2026)

6/8 (75%)

$34.51 (44.53%)

366

Buy Since 08-Nov-2024

$112

$47.34 (73.21%)

$117

1 months 24 days ago
(07-Aug-2026)

4/10 (40%)

$35.24 (45.91%)

448

Buy Since 07-Mar-2023

$110

$45.34 (70.12%)

$96

1 months 24 days ago
(07-Aug-2026)

20/25 (80%)

$33.24 (43.30%)

429

Show more analysts

Please expand the browser size to see the chart

What is CYTK (Cytokinetics) average time for price targets to be met?

On average it took 367 days for the stock forecasts to be reached, with an average price target met ratio of 79.02%.

Which analyst most recently updated their price target on CYTK (Cytokinetics)?

Joseph Pantginis

Which analyst has the most public recommendations on CYTK (Cytokinetics)?

Joseph Pantginis has 5 price targets and 3 ratings on CYTK

Which analyst is the currently most bullish on CYTK (Cytokinetics)?

Joseph Pantginis with the highest potential upside of $75.34

Which analyst is the currently most reserved on CYTK (Cytokinetics)?

Ritu Baral with the lowest potential downside of -$55.66
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?